# Zarontin

NDC: 0071-0237
Generic name: Ethosuximide
Labeler / Manufacturer: Parke-Davis Div of Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20000922

FDA application: NDA012380

## Active ingredients

- ETHOSUXIMIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0071-0237"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0071-0237
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e008f33-70a1-4bc6-b3a0-d45214418ab6